Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

In a report released today, Tim Anderson from Bank of America Securities reiterated a Sell rating on Amgen (AMGN – Research Report), with a ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Amgen Inc (AMGN) stock saw a decline, ending the day at $280.3 which represents a decrease of $-2.65 or -0.94% from the prior close of $282.95. The stock opened at $280.13 and touched a low of $279.97 ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The latest trading day saw Amgen (AMGN) settling at $280.30, representing a -0.94% change from its previous close.

Amgen Inc (AMGN) stock saw a decline, ending the day at $275.42 which represents a decrease of $-2.46 or -0.89% from the prior close of $277.88. The stock opened at $276.26 and touched a low of $273.5 ...

Today, Benzinga 's options scanner spotted 28 uncommon options trades for Amgen. This isn't normal. The overall sentiment of ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Avior Wealth Management LLC trimmed its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 49.8% during the fourth quarter, ...

Equities research analysts at William Blair reduced their FY2024 earnings per share estimates for shares of Amgen in a ...

In a report released today, Gregory Renza from RBC Capital maintained a Buy rating on Amgen (AMGN – Research Report), with a price target of ...